🇺🇸
United States · US · US:46287-045_cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93
TADLIQ
Orange BookUNIISPLATC G04BE08
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerCMP Pharma, Inc.
CountryUS (United States)
ATC codeG04BE08
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc114628704515150 mL in 1 BOTTLE (46287-045-15)
Annotations
UNII (FDA Substance ID)
742SXX0ICT
TADALAFIL
RxCUI 358263
Orange Book
N214522
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "742SXX0ICT",
"rxcui": "358263",
"inchikey": "WOXKDUGGOYFFRN-IIBYNOLFSA-N",
"display_name": "TADALAFIL",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"7a909b25-3772-403e-a5fe-e4a040293fb7": {
"match": "brand_token",
"title": "TADLIQ (TADALAFIL) SUSPENSION [CMP PHARMA, INC.]",
"spl_version": "6",
"published_date": "2025-12-24"
}
},
"productid": "46287-045_cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93",
"productndc": "46287-045",
"dosage_form": "SUSPENSION",
"orange_book": {
"appl_no": "214522",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "20MG/5ML",
"product_no": "001",
"approval_date": "Jun 17, 2022"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "TADALAFIL",
"proprietary_name": "TADLIQ",
"active_ingred_unit": "mg/5mL",
"application_number": "NDA214522",
"marketing_category": "NDA",
"nonproprietary_name": "Tadalafil",
"start_marketing_date": "20220830",
"active_numerator_strength": "20"
}Related drugs
Other records sharing ATC code G04BE08.
Access this data programmatically
Query TADLIQ and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.